Skip to content

Discontinued — last reported Q4 '25

Total Revenue at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$11.49B+2.6%
Eli Lilly logo
Eli LillyLLY
$19.8B+55.5%
Pfizer logo
PfizerPFE
$14.45B+5.4%
Merck & Co. logo
Merck & Co.MRK
$16.29B+4.9%
Amgen logo
AmgenAMGN
$8.62B+5.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$194.52M+66.8%

Other financials

Income statement

See full
Operating income-$445.2M-84.9%
Net income-$453.8M-113%
EPS (diluted)-$2.29-103%

Balance sheet

See full
Cash & equivalents$440.9M+32.2%
Total debt$156.6M+16.6%
Total equity$1.5B-27.8%
Total assets$2.3B-4.7%

Cash flow

See full
Operating cash flow-$354.2M-82.2%
CapEx$1.5M-52.9%
Free cash flow-$355.7M-79.9%

Valuation

See full
Market cap$40.63B+495%
Enterprise value$40.35B+515%

Profitability

See full
Operating margin-88,031.9%-89,488pp
Net margin-76,423.3%-77,733pp
FCF margin-74,273.9%-75,457pp

Returns & leverage

See full
Return on equity-76.7%-923pp
Debt / equity0.1×0.0×
Current ratio6.8×-6.7×

Where this comes from

Reported directly by Revolution Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Revolution Medicines, Inc.’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revolution Medicines, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revolution Medicines, Inc.'s total revenue?
Revolution Medicines, Inc. (RVMD) reported total revenue of $0 in Q4 2025.
What is the long-term trend for Revolution Medicines, Inc.'s total revenue?
Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $29.39M to $0.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.